- Home
- OMCL vs BSTZ Comparison
OMCL vs BSTZ Comparison
Compare OMCL & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- BSTZ
- Stock Information
- Founded
- OMCL 1992
- BSTZ 2019
- Country
- OMCL United States
- BSTZ United States
- Employees
- OMCL N/A
- BSTZ N/A
- Industry
- OMCL Computer Manufacturing
- BSTZ Trusts Except Educational Religious and Charitable
- Sector
- OMCL Technology
- BSTZ Finance
- Exchange
- OMCL Nasdaq
- BSTZ Nasdaq
- Market Cap
- OMCL 2.0B
- BSTZ 1.6B
- IPO Year
- OMCL 2001
- BSTZ N/A
- Fundamental
- Price
- OMCL $45.67
- BSTZ $20.65
- Analyst Decision
- OMCL Buy
- BSTZ
- Analyst Count
- OMCL 6
- BSTZ 0
- Target Price
- OMCL $50.83
- BSTZ N/A
- AVG Volume (30 Days)
- OMCL 598.3K
- BSTZ 303.2K
- Earning Date
- OMCL 10-30-2024
- BSTZ 01-01-0001
- Dividend Yield
- OMCL N/A
- BSTZ 8.31%
- EPS Growth
- OMCL N/A
- BSTZ N/A
- EPS
- OMCL N/A
- BSTZ 0.71
- Revenue
- OMCL $1,064,205,999.00
- BSTZ N/A
- Revenue This Year
- OMCL N/A
- BSTZ N/A
- Revenue Next Year
- OMCL $4.97
- BSTZ N/A
- P/E Ratio
- OMCL N/A
- BSTZ $26.69
- Revenue Growth
- OMCL N/A
- BSTZ N/A
- 52 Week Low
- OMCL $25.12
- BSTZ $14.11
- 52 Week High
- OMCL $55.75
- BSTZ $19.43
- Technical
- Relative Strength Index (RSI)
- OMCL 48.71
- BSTZ 56.53
- Support Level
- OMCL $48.21
- BSTZ $20.95
- Resistance Level
- OMCL $53.31
- BSTZ $21.40
- Average True Range (ATR)
- OMCL 2.62
- BSTZ 0.29
- MACD
- OMCL -0.29
- BSTZ 0.02
- Stochastic Oscillator
- OMCL 36.80
- BSTZ 48.68
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.